Glaukos Competitors and Similar CompaniesClear all
Glaukos's competitors and similar companies include ARTIVION and Livanova.
 Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. |  ARTIVION CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. | ||
Founding Date | Founding Date 1998 | Founding Date 1984 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | Locations Kennesaw, US HQ Paris, FR Singapore, SG Guildford, GB Austin, US | Locations London, GB HQ Dandenong South, AU Wien, AT Markham, CA Bogotá, CO Helsinki, FI Helsinki, FI see more |
Employees | Employees 90716% increase | Employees 1,2009% increase | Employees 2,900 |
Valuation ($) | Valuation ($) 7.6 b | Valuation ($) 1.1 b | Valuation ($) 2.9 b |
Financial | |||
Revenue (est.) | Revenue (est.) $507.4m (FY, 2025) | Revenue (est.) $441.3m (FY, 2025) | Revenue (est.) $1.4b (FY, 2025) |
Cost of goods | Cost of goods $111.8m (FY, 2025) | Cost of goods $157.1m (FY, 2025) | Cost of goods $448.2m (FY, 2025) |
Gross profit | Gross profit $282.8m (FY, 2025) | Gross profit $284.2m (FY, 2025) | Gross profit $939.9m (FY, 2025) |
Net income | Net income ($187.7m) (FY, 2025) | Net income $9.8m (FY, 2025) | Net income ($242.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 115m | Total funding raised $ 1.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ARTIVION
HQ
Kennesaw, US
Employees
1,200↑ 9% increase
CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair.
View company